In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheres

Journal of Pharmaceutical Sciences

Volumn 87, Issue 10, 1998, Pages 1242-1248

  Neal, Jonathan C ^a   Stolnik, Snow ^a   Schacht, Etienne ^b   Kenawy, El Rafaie ^b   Garnett, Martin C ^a   Davis, Stanley S ^a   Illum, Lisbeth ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; COPOLYMER; IODINE 125; MACROGOL; NANOPARTICLE; PLASMA PROTEIN; POLOXAMINE 908; POLYGLACTIN; POLYMER; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL MODIFICATION; COVALENT BOND; DESORPTION; DRUG STABILITY; ISOTOPE LABELING; NONHUMAN; RAT; SERUM;

EID: 0031668265     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js970462j     Document Type: Article

References (50)

1. Davies, W. L.; Grunert, R. R.; Haft, R. F.; McGahen, J. W.; Neumayer, E. M.; Paulshock, M.; Watts, J. C.; Wood, T. R.; Herman, E. C.; Hoffman, C. E. Antiviral activity of 1-adamantanamine (amantadine). Science 1964, 144, 862-863.
2. Ruigrok, R. W. H.; Hirst, E. M. A.; Hay, A. J. The specific inhibition of influenza A virus maturation by amantadine an electron microscopic examination. J. Gen. Virol. 1991, 72, 191-195.
3. Sugrue, R. J.; Bahadur, G.; Zambon, M. C.; Hall-Smith, M.; Douglas, A. R.; Hay, A. J. Specific structural alteration of the influenza hemagglutinin by amantadine. EMBO J. 1990, 9, 3469-3476.
4. Jackish, R.; Link, T.; Neufang, B.; Koch, R. Studies on the mechanism of action of the antiparkinsonian drugs memantine and amantadine: no evidence for direct dopaminergic or antimuscarinic properties. Arch. Int. Pharmakodyn. Ther. 1992, 320, 21-42.
5. Rabey, J. M.; Nissipeanu, P.; Korczyn, A. D. Efficacy of memantine, on NMDA receptor antagonist, in the treatment of Parkinson's disease. J. Neural. Transm. Park. Dis. Dement. Sect. 1992, 4, 277-282.
6. Pinto, L. H.; Holsinger, L. H.; Lamb, R. A. Influenza virus M2 protein has ion channel activity. Cell 1992, 69, 517-528.
7. Hay, A. J. The mechanism of action of amantadine and rimantadine against influenza viruses. In Concepts in Viral Pathogeneses III; Notkins, A. L., Oldstone, M. B. A., Eds.; Springer-Verlag; New York, 1989, pp 361-367.
8. Sugrue, R. J.; Hay, A. J. Structural characteristics of the M2 protein of influenza viruses: evidence that it forms a tetrameric channel. Virology. 1991, 180, 617-624.
9. Zhirnov, O. P. Solubilization of matrix protein M1/M from virions occurs at different pH for orthomyxo-and paramyxo-viruses. Virology 1990, 176, 274-279.
10. Lamb, R. A. The genes and proteins of influenza viruses. In The Influenza Viruses, Plenum Publishing Corp.: New York, 1989; Krug, R. M., Ed.; pp 1-87.
11. Marsh, M.; Helenius, A. Virus entry into animal cells. Adv. Virus Res. 1989, 36, 107-151.
12. Freisleben, H. J.; Waltinger, G.; Schatten, W.; Zimmer, G. Influences of Tromantadine and Nonoxinol 9 on the stability of red cell membrane. Arzneim. Forsch / Drug Res. 1989, 39, 1202-1205.
13. Phonphok, Y.; Rosenthal, K. S. Stabilization of clathrin coated vesicles by amantadine, tromantadine and other hydrophobic amines. FEBS Lett. 1991, 281, 188-190.
14. Borman, J. Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur. J. Pharmacol. 1989, 166, 591-592.
15. Kornhuber, J.; Borman, J.; Retz, W.; Hubers, M.; Riederer, P. Memantine dosplaces [3H]MK-801 at therapeutic concentration in postmortem human frontal cortex. Eur. J. Pharmacol. 1989, 166, 589-590.
16. Moryl, D.; Danysz, S.; Quack, G. Potential antidepresseve properties of amantadine, memantine and bifemelane. Pharmacol. Toxicol. 1993, 72, 394-397.
17. Weller, M.; Finiels-Marlier, F.; Paul, S. M. NMDA receptor-mediated glutamate toxicity of cultured cerebellar, cortical and mesencephalic neurons: neuroprotective properties of amantadine and memantine. Brain. Res. 1993, 613, 143-148.
18. 3H] Phencyclidine interactions with the nicotinic acetylcholine receptor channel and its inhibition by psychotropic, antipsychotic, opiate, antidepressant, antibiotic, antiviral, and antiarrhythmic drugs. Mol. Pharmacol. 1982, 22, 72-81.
19. Eletr, S.; Williams, M. A.; Watkins, T.; Keith, A. D. Perturbations of the dynamics of lipid alkyl chains in membrane systems: Effect on the activity of membrane-bound enzyme. Biochim. Biophys. Acta 1974, 339, 190-201.
20. Jain, M. K.; Yen-Min Wu, N.; Morgan, T. K., Jr.; Briggs, M. S.; Murray, R. K., Jr. Phase transition in a lipid bilayer. II. Influence of adamantane derivatives. Chem. Phys. Lipids. 1976, 17, 71-78.
21. Duff, K. C.; Cudmore, A. J.; Bradshaw, J. P. The location of amantadine hydrochloride and free base within phospholipid multilayers: a neutron and X-ray diffraction study. Biochim. Biophys. Acta 1993, 1145, 149-156.
22. Hyde, J. S.; Subczynski, W. K. Spin-label oximetry. In Biological Magnetic Resonance; Berliner, L. J., Reuben, J., Eds.; Plenum Press: New York, 1989; Vol. 8, Spin Labeling: Theory and Applications, pp 399-425.
23. Lecuyer, H.; Derivichian, D. G. Structure of aqueous mixtures of lecithin and cholesterol. J. Mol. Biol. 1969, 45, 39-58.
24. Higuchi, T.; Davis, S. S. Thermodynamic analysis of structure-activity relationships of drugs: Prediction of optimal structure. J. Pharm. Sci. 1970, 59, 1376-1383.
25. Tsuzuki, N.; Hama, T.; Hibi, T.; Konishi, R.; Futaki, S.; Kitagawa, K. Amantadine as a brain-directed drug carrier for poorly absorbed drug: Antinociseptive efffects of [D-Ala2]-Leu-Enkephalin derivatives conjugated with the 1-Adamantane moiety. Biochem. Pharmacol. 1991, 41, R5-R8.
26. Griffith, O. H.; Dehlinger, P. J.; Van, S. P. Shape of the hydrophobic barrier of phospholipid bilayers. Evidence for water penetration in biological membranes. J. Membr. Biol. 1974, 15, 159-192.
27. Subczynski, W. K.; Wisniewska, A.; Yin, J. J.; Hyde, J. S.; Kusumi, A. 1994. Hydrophobic barrier of bilayer membrane formed by reduction of water penetration by alkyl chain unsaturation and cholesterol. Biochemistry 1994, 33, 7670-7681.
28. Gaffney, B. J.; McNamee, C. M. Spin-label measurement of membranes. With appendix: a use of computers in EPR spectroscopy. In Methods in Enzymology; Fleisher, S., Packer, L., Eds.; Academic Press: New York, S. Francisco, London, 1974, pp 161-198.
29. Pezeshk, A.; Pezeshk, V.; Wojas, J.; Subczynski, W. K. Partitional and motional properties of a spin-labeled Daunomycin in lipid bilayers. An EPR study. J. Inorg. Biochem. 1992, 46, 67-76.
30. Eriksson, U. G.; Tozer, T. N.; Sosnovsky, G.; Lukszo, J.; Brasch, R. C. Human erytrocyte membrane permeability and nitroxyl spin-label reduction. J. Pharm. Sci. 1986, 75, 334-337.
31. McConnell, H. M. Molecular motion in biological membranes. In Spin Labeling, Theory and Application; Berliner, L. J., Ed.; Academic Press: New York; 1974, pp 525-560.
32. Sefton, B. M.; Gaffney, B. J. Effects of the viral proteins on the fluidity of the membrane lipids in Sindbis virus. J. Mol. Biol. 1974, 90, 343-358.
33. Moore, N. F.; Barenholtz, Y.; Wagner, R. R. Microviscosity of togavirus membranes studied by fluorescence depolarization: influence of envelope proteins and the host cell. J. Virol. 1976, 19, 126-135.
34. Greenberg, N.; Rottem, S. Composition and molecular organization of lipids and proteins in the envelope of mycoplasmavirus MVL2. J. Virol. 1979, 32, 717-726.
35. DeLuca, N.; Keith, A.; Snipes, W. Studies with hydrophobic spin-labeled virucidal agent. Antimicrob. Agents Chemother 1980, 17, 63-70.
36. Landsberger, F. R.; Compans, R. W.; Choppin, P. W.; Lenard, J. Organization of the lipid phase in viral membranes. Effects of independent variation of the lipid and the protein composition. Biochemistry, 1973, 12, 4498-4502.
37. Kawasaki, K; Yin, J. J.; Subczynski, W. K; Hyde, J. S.; Ohnishi, S. I.; Kusumi, A. Observation of lipid exchange reaction between two domains in the outer membrane of influenza virus by a pulse ESR spin labeling method. XIII International Conference on Magnetic Resonance in Biologi-cal Systems; Madison, WI, Aug 14-19, 1988; pp 13-31.
38. Cupp, J.; Klymkowski, M.; Sands, J.; Keith, A.; Snipes, W. Effect of lipid alkyl chain perturbations on the asembly of baceriophage PM2. Biochim. Biophys. Acta 1975, 389, 345-375.
39. Cheetham, J. J.; Epand, R. M. Comparison of the interaction of the anti-viral chemotherapeutic agents amantadine and tromantadine with phospholipid membranes. Biosci. Rep. 1987, 7, 225-230.
40. Rozantsev, E. G. Free Nitroxyl Radicals; Plenum Press: New York, London, 1970.
41. Emanuel, N. M.; Konovalova, N. P.; Diatchkovskaya, R. F.; Denisova, L. K. Nitroxyl derivatives of Rubomycin. Antibiotiki 1982, 27, 811-815.
42. Emanuel, N. M.; Konovalova, N. P.; Diatchkovskaya, R. F. Potential anticancer agents-nitroxyl derivatives of rubomycin. Neoplasma 1985, 32, 285-292.
43. Klenner, T.; Berger, M. R.; Sosnovsky, G.; Rao, N. U.; Winger, F.; Schmahl, D. Evaluation of spin-labeled TEPA and CCNU analogues against osteosarcoma and MNU-induced mammary carcinoma of the SD-rat. Arch. Geschwulstforsch. 1989, 59 (4), 251-256.
44. Shiryaeva, O. A.; Semenova, M. A.; Sibeldina, L. A.; Goncharova, S. A.; Konovalova, N. P. The study of phosphorous-containing metabolites in anthracycline resistant murine leukemia P388 cells. Exp. Oncol. 1989, 11, 70-73.
45. Sosnovsky, G.; Rao, N. U. In the search for new anticancer drugs. XXII: Synthesis and anticancer evaluation of some dipeptides containing N-nitrosochloroethylamino and chloroethylamino moieties. J. Pharm. Sci. 1990, 79, 369-370.
46. Pezeshk, A.; Pezeshk, V. Spectroscopic and biological studies of spin-labeled tetracycline. Life Sci. 1992, 50, 1561-1565.
47. Emanuel, N. M.; Konovalova, N. P. Nitroxyl radicals for cancer chemotherapy. In Bioactive Spin Labels; Zhdanov, R. I., Ed.; Springer-Verlag: New York, 1991; pp 439-460.
48. Samuni, A.; Krishna, C. M.; Riesz, P.; Finkelstein, E.; Russo, A. A novel metal free low molecular weight Superoxide dismutase mimic. J. Biol. Chem. 1988, 236, 17921-17924.
49. Mitchel, J. B.; Samuni, A.; Krishna, M. C.; DeGraff, W. G.; Ahn, M. S.; Samuni, U.; Russo, A. Biologically active metal-independent Superoxide dismutase mimics. Biochemistry 1990, 29, 2802-2807.
50. Wisniewska, A.; Ligeza, A.; Subczynski, W. K. Reoxidation of the reduced nitroxide radical spin label TEMPONE: involvment of oxygen and oxygen-derived active forms. Curr. Top. Biophys. 1992, 16, 85-90.